GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioteque Corp (ROCO:4107) » Definitions » Capital Expenditure

Bioteque (ROCO:4107) Capital Expenditure : NT$-101.88 Mil (TTM As of Mar. 2025)


View and export this data going back to 2002. Start your Free Trial

What is Bioteque Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Bioteque's cash flow for capital expenditures for the three months ended in Mar. 2025 was NT$-14 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-101.88 Mil.

Bioteque Capital Expenditure Historical Data

The historical data trend for Bioteque's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioteque Capital Expenditure Chart

Bioteque Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -171.78 -550.87 -726.83 -73.05 -98.43

Bioteque Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.73 -44.81 -19.55 -23.35 -14.17

Bioteque Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-101.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioteque Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioteque Corp (ROCO:4107) » Definitions » Capital Expenditure
Comparable Companies
ROCO:1565 ROCO:5312 TPE:1786 ROCO:4126 ROCO:6499 ROCO:6612 TPE:6782 TPE:4771 TPE:4737 TPE:1783 ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN
Traded in Other Exchanges
N/A
Address
Chang-An E. Road, 5th Floor-6, No.23, Section 1, Taipei, TWN, 104
Website
https://www.bioteq.com.tw
Bioteque Corp is engaged in manufacturing, trading, and selling medical equipment and instruments. The company operates in different segments such as Manufacturing medical disposables for hemodialysis use, and selling them to dealers and retailers; Manufacturing and selling catheters for healthcare and medical PVC IV bags to medical organizations; Manufacturing and selling medical key components and inner catheters to the medical organization; and Other segment. Geographically, the company generates a majority of its revenue from Asia and the rest from North America, South America, and other regions.

Bioteque Headlines

No Headlines